Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$35.55 - $43.57 $355,677 - $435,917
10,005 New
10,005 $434,000
Q1 2022

May 16, 2022

SELL
$42.23 - $54.3 $405,745 - $521,714
-9,608 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $486,356 - $542,563
9,608 New
9,608 $534,000
Q2 2021

Aug 16, 2021

SELL
$46.28 - $52.75 $215,155 - $245,234
-4,649 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$46.25 - $56.02 $7.71 Million - $9.33 Million
-166,617 Reduced 97.29%
4,649 $227,000
Q4 2020

Feb 16, 2021

BUY
$46.09 - $54.74 $3.91 Million - $4.64 Million
84,834 Added 98.15%
171,266 $9.05 Million
Q3 2020

Nov 16, 2020

BUY
$42.51 - $52.42 $3.67 Million - $4.53 Million
86,432 New
86,432 $4.52 Million
Q1 2020

May 15, 2020

SELL
$33.17 - $41.6 $12.8 Million - $16.1 Million
-385,890 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$25.41 - $43.1 $5.68 Million - $9.63 Million
223,490 Added 137.62%
385,890 $13 Million
Q3 2019

Nov 14, 2019

SELL
$32.73 - $40.81 $1.89 Million - $2.35 Million
-57,691 Reduced 26.21%
162,400 $5.35 Million
Q2 2019

Aug 14, 2019

SELL
$35.73 - $41.39 $416,325 - $482,276
-11,652 Reduced 5.03%
220,091 $8.93 Million
Q1 2019

May 15, 2019

SELL
$33.78 - $40.68 $113,365 - $136,522
-3,356 Reduced 1.43%
231,743 $9.43 Million
Q4 2018

Feb 14, 2019

SELL
$32.65 - $37.95 $5 Million - $5.81 Million
-153,207 Reduced 39.46%
235,099 $8.1 Million
Q3 2018

Nov 14, 2018

BUY
$35.99 - $39.39 $9.42 Million - $10.3 Million
261,625 Added 206.52%
388,306 $14.7 Million
Q2 2018

Aug 14, 2018

BUY
$31.23 - $37.47 $3.7 Million - $4.44 Million
118,498 Added 1448.1%
126,681 $4.58 Million
Q1 2018

May 15, 2018

BUY
$31.01 - $34.72 $253,754 - $284,113
8,183 New
8,183 $265,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.